AR038145A1 - Composicion de politartrato - Google Patents

Composicion de politartrato

Info

Publication number
AR038145A1
AR038145A1 ARP030100102A ARP030100102A AR038145A1 AR 038145 A1 AR038145 A1 AR 038145A1 AR P030100102 A ARP030100102 A AR P030100102A AR P030100102 A ARP030100102 A AR P030100102A AR 038145 A1 AR038145 A1 AR 038145A1
Authority
AR
Argentina
Prior art keywords
active material
pharmaceutically active
composition
composition according
polythartrate
Prior art date
Application number
ARP030100102A
Other languages
English (en)
Inventor
Gesine Schliecker
Carsten Schmidt
Stefan Fuchs
Thomas Kissel
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of AR038145A1 publication Critical patent/AR038145A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Composiciones de politartrato para la liberación pulsátil de un material farmacéuticamente activo que se encuentra en forma de una tableta comprimida, un procedimiento para preparar una composición de este tipo y el uso de la misma. Reivindicación 1: Una composición farmacéutica que comprende un polímero de politartrato y por lo menos un material farmacéuticamente activo caracterizada porque la composición es capaz de liberar el material farmacéuticamente activo en una manera pulsátil y es obtenible formando la tableta con una fuerza de compresión entre 10 y 65 kN/ cm2. Reivindicación 10: La composición de acuerdo con la reivindicación 9, caracterizada porque el material farmacéuticamente activo es un agonista GnRH. Reivindicación 11: La composición de acuerdo con la reivindicación 10, caracterizada porque el material farmacéuticamente activo es buserelina. Reivindicación 12: La composición de acuerdo con la reivindicación 11, caracterizada porque el material farmacéuticamente activo es azagly nafarelina.
ARP030100102A 2002-01-16 2003-01-15 Composicion de politartrato AR038145A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02075176 2002-01-16

Publications (1)

Publication Number Publication Date
AR038145A1 true AR038145A1 (es) 2004-12-29

Family

ID=8185536

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030100102A AR038145A1 (es) 2002-01-16 2003-01-15 Composicion de politartrato

Country Status (7)

Country Link
US (1) US20050118271A1 (es)
EP (1) EP1467716A2 (es)
JP (1) JP4616556B2 (es)
AR (1) AR038145A1 (es)
AU (1) AU2003235708A1 (es)
CA (1) CA2471483A1 (es)
WO (1) WO2003059329A2 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8765167B2 (en) 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US11207805B2 (en) 2001-10-12 2021-12-28 Aquestive Therapeutics, Inc. Process for manufacturing a resulting pharmaceutical film
US8900498B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for manufacturing a resulting multi-layer pharmaceutical film
US20070281003A1 (en) 2001-10-12 2007-12-06 Fuisz Richard C Polymer-Based Films and Drug Delivery Systems Made Therefrom
US20110033542A1 (en) 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
US20190328679A1 (en) 2001-10-12 2019-10-31 Aquestive Therapeutics, Inc. Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US8603514B2 (en) 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US10285910B2 (en) 2001-10-12 2019-05-14 Aquestive Therapeutics, Inc. Sublingual and buccal film compositions
US8900497B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for making a film having a substantially uniform distribution of components
US7357891B2 (en) 2001-10-12 2008-04-15 Monosol Rx, Llc Process for making an ingestible film
CN101466317B (zh) * 2006-06-12 2011-08-31 史密夫和内修有限公司 用于进行胫骨切除的系统、方法和装置
CA2660647C (en) 2006-06-14 2015-07-28 Intervet International B.V. A suspension comprising benzimidazole carbamate and a polysorbate
US9149959B2 (en) 2010-10-22 2015-10-06 Monosol Rx, Llc Manufacturing of small film strips
US10071199B2 (en) 2013-03-15 2018-09-11 Incube Labs, Llc Multi-stage biodegradable drug delivery platform
WO2016020308A1 (en) * 2014-08-04 2016-02-11 Janssen Sciences Ireland Uc Compacted solid dosage form
JP2019519487A (ja) 2016-05-05 2019-07-11 アクエスティブ セラピューティクス インコーポレイテッド 送達増強エピネフリン組成物
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3936191C2 (de) * 1989-10-31 1996-10-17 Boehringer Ingelheim Kg Neue Copolymere aus Milchsäure und Weinsäure, ihre Herstellung sowie ihre Verwendung
EP0514790A2 (de) * 1991-05-24 1992-11-25 Hoechst Aktiengesellschaft Polykondensate, die Weinsäurederivate enthalten, Verfahren zu ihrer Herstellung und Verwendung derselben
US5838571A (en) * 1996-01-29 1998-11-17 Alza Corporation Tablet press monitoring and controlling method and apparatus
CA2250908C (en) * 1996-04-30 2012-03-13 Takeda Chemical Industries, Ltd. Combined use of gnrh agonist and antagonist
IL145106A0 (en) * 2000-08-30 2002-06-30 Pfizer Prod Inc Intermittent administration of a geowth hormone secretagogue

Also Published As

Publication number Publication date
CA2471483A1 (en) 2003-07-24
WO2003059329A2 (en) 2003-07-24
US20050118271A1 (en) 2005-06-02
AU2003235708A1 (en) 2003-07-30
WO2003059329A3 (en) 2003-12-18
EP1467716A2 (en) 2004-10-20
JP2005516966A (ja) 2005-06-09
JP4616556B2 (ja) 2011-01-19

Similar Documents

Publication Publication Date Title
AR038145A1 (es) Composicion de politartrato
BR0107874A (pt) Implante farmacêutico para controlavelmente liberar uma droga, método para controlavelmente liberar uma droga em um indivìduo, e, método para preparar o implante
ECSP088106A (es) Formas de dosificación de liberación retardada oral altamente biodisponible del succinato de o-desmetilvenlafaxina
CO5390072A1 (es) Compuestos organicos
BRPI0707044B8 (pt) comprimido matricial insolúvel em água e processo de fabricação de comprimidos matriciais
ES2167061T3 (es) Formas de dosificacion para mejorar la disfuncion erectil en pacientes de sexo masculino.
AR054382A1 (es) Formulacion de compresion directa de un inhibidor de dipeptidil-peptidasa iv y una glitazona y proceso
AR074528A1 (es) Dispositivos intravaginales con un soporte rigido, metodos para su fabricacion y sus usos
AR042937A2 (es) Formulaciones de liberacion sostenida para secretagogos de hormona del crecimiento
AR018143A1 (es) Formulacion para preparar un comprimido de desintegracion rapida, comprimidos de desintegracion rapida, especialmente comprimidos de desintegracionrapida en la boca
MX2008012731A (es) Tabletas de paracetamol de liberacion rapida.
CR7661A (es) Composicion de comprimido de liberacion sostenida de pramipexol
PE20030591A1 (es) Formulaciones de acitromicina directamente compresibles
AR049000A1 (es) Formulacion para compresion directa y proceso para la preparacion de una tableta directamente comprimida
MX9308188A (es) Glucomanano de konjac facilmente disponible, como un excipiente de liberacion sostenida.
AR086971A2 (es) Composiciones orales y sistemas de liberacion
MX2009004203A (es) Combinaciones de paracetamol/ibuprofeno y metodo para su uso.
UY27720A1 (es) Aroilpiridinonas monocíclicas,
CL2007001270A1 (es) Metodo de control de enfermedades de plantas mendiante el uso de una composicion que comprende clorotalonilo en particulas solidas de entre 0,1 a 0,3 micrones.
UY30961A1 (es) Comprimido famacéutico, capa de comprimido comprendiendo ingrediente activo telmisartan, un agente basico y sorbitol, proceso de preparacion y aplicaciones,
ATE476997T1 (de) Zusammensetzung und dosierform mit einer festen oder halbfesten matrix
AR034517A1 (es) Formulacion farmaceutica
AR019699A1 (es) Composicion farmaceutica para el tratamiento de disfuncion de la evacuacion y uso de la misma para la preparacion de un agente terapeutico
GB0004827D0 (en) Compositions
ES2173823T1 (es) Comprimido para chupar que contiene ambroxol.

Legal Events

Date Code Title Description
FB Suspension of granting procedure